MFT Pharma Solutions, Science park, Leiden (2026)

MFT is a trusted consultancy partnering with pharmaceutical, biotech, and vaccine manufacturers to achieve compliance, operational excellence, and global growth.

28/05/2026

📢 ISO 9000:2026 — Evolution, Not Revolution

The upcoming revision of ISO 9000:2026 is not about adding new requirements or expanding audit expectations. Instead, it is focused on something equally important: clarity, consistency, and better interpretation of quality management principles.

So, what is changing?

ISO 9000:2026 strengthens understanding—it does not complicate compliance.

For quality professionals and auditors, this revision is an opportunity to improve training, communication, and consistent interpretation without unnecessary procedural burden.

📌 The future of quality management is not more complexity—it is greater clarity.

How is your organization preparing for the upcoming ISO revisions?

24/05/2026

Digital Transformation Starts with the Right Fit
Digital transformation is not about implementing technology for the sake of technology. It is about choosing the right solution that truly fits your company, your quality system, and your operational processes.
At MFT Consult, we support organizations across the life sciences sector in transforming quality processes, strengthening data integrity, and selecting solutions that create real value—not unnecessary complexity.
Whether you are looking to improve:
✅ Quality Management Systems (QMS)
✅ Data Integrity & Compliance (ALCOA+)
✅ eQMS, LIMS, ERP, or MES implementation
✅ Process efficiency and audit readiness
We help you identify, design, and implement the solution that works for your organization—not a one-size-fits-all approach.

📩 If you are looking to transform your quality processes, reach out to explore the right digital solution for your company and processes.

17/02/2026

MFT Consult wishes our valued partners and colleagues a blessed Ramadan.
May this month bring strength, reflection, and meaningful progress.

14/02/2026

The 2022 revision of shifted the regulatory focus from contamination detection to contamination governance.

The expectation is no longer isolated monitoring activities. It is a structured, science-based, risk-driven Contamination Control Strategy (CCS).

QA leadership must now demonstrate:

• Integrated oversight across EM, cleaning validation, utilities, and facility controls
• Data-driven trend visibility and statistical justification
• Clear linkage between excursions, investigations, and CCS updates
• Lifecycle-based contamination risk management

Environmental monitoring is one verification layer, but governance requires system integration.

At MFT Pharma Solutions, we support manufacturers in structuring Annex 1-aligned contamination control frameworks and enabling digitalization strategies that integrate monitoring, trending, and risk management.

This includes implementation and validation support of integrated contamination control and environmental monitoring platforms, such as Novatek International ’s CC/EM software, to ensure audit-traceable data integrity and real-time governance visibility.

Digitalization is not an IT upgrade. It is a quality system maturity decision.

13/02/2026

Grateful to have attended WHX Dubai this week.
Beyond the scale of the exhibition, what stood out most were the discussions around regional manufacturing ambitions, localization strategies, and the increasing focus on regulatory maturity across the GCC.
As governments continue to prioritize healthcare security and local production, market entry into the GCC is no longer simply a commercial decision, It is a regulatory, technical, and strategic undertaking.
Successful market access requires:
~ Clear regulatory pathway mapping across GCC jurisdictions ~ Early alignment on GMP expectations and inspection readiness
~ Structured technology transfer frameworks ~ Strong CMC documentation and dossier positioning ~ Facility design that anticipates both local and international compliance standards

Pharma Solutions ,we see growing demand from manufacturers seeking structured entry strategies into GCC markets - whether through local partnerships, greenfield facilities, or technology transfer to regional sites.
The opportunity is significant.
But so is the complexity.
Sustainable market entry in the GCC requires more than distribution, it requires regulatory credibility, operational readiness, and long-term positioning.
Looking forward to continuing conversations with stakeholders committed to building compliant, future-ready manufacturing ecosystems across the region.

24/12/2025

As the year comes to a close, we extend our sincere thanks to our partners and collaborators.
Wishing you a Merry Christmas and a successful New Year ahead.
MFT Consult – Your GxP Excellence Partner.

Adres

Science Park
Leiden

Website

https://www.mft-consult.com/, http://mftpharmasolutions.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer MFT Pharma Solutions nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact

Stuur een bericht naar MFT Pharma Solutions:

MFT Pharma Solutions